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A B S T R A C T
Aims: Little is known about diabetes in hospitalized Native Hawaiians and Asian Americans. We deter-
mined the burden of diabetes (both diagnosed and undiagnosed) among hospitalized Native Hawaiian,
Asian (Filipino, Chinese, Japanese), and White patients.
Methods: Diagnosed diabetes was determined from discharge data from amajor medical center in Hawai‘i
during 2007–2008. Potentially undiagnosed diabetes was determined by Hemoglobin A1c ≥ 6.5% or
glucose ≥ 200mg/dl values for those without diagnosed diabetes. Multivariable log-binomial models pre-
dicted diabetes (potentially undiagnosed and diagnosed, separately) controlling for socio-demographic factors.
Results: Of 17,828 hospitalized patients, 3.4% had potentially undiagnosed diabetes and 30.5% had di-
agnosed diabetes. In multivariable models compared to Whites, Native Hawaiian and all Asian subgroups
had signiﬁcantly higher percentages of diagnosed diabetes, but not of potentially undiagnosed diabe-
tes. Potentially undiagnosed diabetes was associated with signiﬁcantly more hospitalizations during the
study period compared to both those without diabetes and those with diagnosed diabetes. In all racial/
ethnic groups, those with potentially undiagnosed diabetes also had the longest length of stay and were
more likely to die during the hospitalization.
Conclusions: Hospitalized Native Hawaiians (41%) and Asian subgroups had signiﬁcantly higher overall
diabetes burdens compared to Whites (23%). Potentially undiagnosed diabetes was associated with poor
outcomes. Hospitalized patients, irrespective of race/ethnicity, may require more effective inpatient iden-
tiﬁcation and management of previously undiagnosed diabetes to improve clinical outcomes.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Native Hawaiians and Asian Americans are two of the fastest
growing populations in the United States (US) [1]. Many members
of these racial/ethnic groups have higher rates of diabetes than non-
HispanicWhites [2]. Little is known about the prevalence of diabetes
in hospitalized Native Hawaiians and Asian American subgroups.
Understanding the full diabetes burden among hospitalized Native
Hawaiian and Asian American populations is important because di-
abetes contributes to poor health outcomes and high health care
costs [3,4]. In the US, approximately 16–25% of hospitalized pa-
tients have diagnosed diabetes [5,6]. Previous studies on diabetes
prevalence among hospitalized patients have either not included,
or have not disaggregated, heterogeneous Asian and Paciﬁc Is-
lander subgroups [6–8].
Estimates of diabetes prevalence in hospitalized patient popu-
lations are complicated by the fact that some patients have
undiagnosed diabetes. Undiagnosed diabetes represents almost one-
third of all diabetes cases in the general population of the United
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States, impacting approximately 8.1 million individuals [9]. Esti-
mates of undiagnosed diabetes among hospitalized patients vary
widely, but are higher than 20% in some settings [10–13].
A prior study of hospitalized Black andWhite patients in Georgia
found that patients with previously undiagnosed hyperglycemia had
higher rates of in-hospital morality (16%) than those with either pre-
viously diagnosed diabetes (3%) or normoglycemia (1.7%) [14]. Poor
outcomes from in-hospital hyperglycemia have also been seen in
other studies [15]. While admissions for hyperglycemia are cur-
rently declining, rates among some populations, including black
Medicare beneﬁciaries, remain high [16].
The prevalence of hyperglycemia and undiagnosed diabetes
among hospitalized Native Hawaiian and Asian American popula-
tions has not been adequately studied. However, high rates of
undiagnosed diabetes have been found among Native Hawaiians and
Asian Americans in the general population and in outpatient setting
in addition to high rates of diagnosed diabetes [2,17,18]. This sug-
gests that undiagnosed diabetes may also be high for hospitalized
patients from these populations. As in-hospital hyperglycemia is as-
sociated with poor clinical outcomes and mortality both for those
with and without a previous diagnosis of diabetes [14,15], this sug-
gests that higher rates of undiagnosed diabetes among Asians, Native
Hawaiians, and other Paciﬁc Islanders might result in worse out-
comes for these groups.
Capitalizing on opportunities for screening and early diagnosis
is of vital importance. The hospital is a convenient setting for early
screening and diagnosis. As type 2 diabetes is usually asymptom-
atic early in its course, chronic complications are already present
in many patients newly diagnosed with the disease, suggesting that
the actual onset of the disease precedes the diagnosis by many years
[19,20]. It is thus important to consider those who may be undi-
agnosed at a point of contact in the health care system as a potential
opportunity to intervene earlier to reduce preventable complica-
tions or morbidity.
The study goals were: (1) to determine the burden of diabetes
(both undiagnosed and diagnosed) among Native Hawaiian and Asian
hospitalized patients, who are known to be at increased risk of di-
abetes, and (2) to consider the consequences of diabetes status in
terms of readmissions over the 2-year study period. Hospitaliza-
tions account for nearly one-third of all health care expenses for
the US’s non-institutionalized population and a considerable amount
of the national diabetes burden [21]. Multiple hospitalizations are
very common among those with diabetes [22]. They may be even
more common among those with undiagnosed diabetes as these
individuals may not be aware of the health impact of diabetes on
their overall health status.
The speciﬁc racial/ethnic groups studied were Native Hawai-
ians, Whites, Filipinos, Chinese, Japanese and other Asian American
or Paciﬁc Islanders (AA/PI). We hypothesized that there would be
differences across Native Hawaiian and Asian American sub-
groups in the prevalence of both diagnosed and potentially
undiagnosed diabetes. Speciﬁcally, we expected that Native Ha-
waiians and Filipinos would have higher rates of both diagnosed
and potentially undiagnosed diabetes compared to Whites even in
multivariable adjustedmodels.We also hypothesized that those with
potentially undiagnosed diabetes would have more readmissions
during the study period than groups with both known diabetes and
without diabetes.
Subjects
Data source
Hawai‘i is one of four states in the US with a ‘majority minori-
ty’ population, and the state with the largest proportion of Asians
and Native Hawaiians. Over 30% of the population is Asian
and at least 25% are Native Hawaiian or other Paciﬁc Islander
[23,24].
Hawai‘i Health Information Corporation data (HHIC)
HHIC collects detailed inpatient discharge data at the patient level
from all hospitalizations by all payers in the state. HHIC inpatient
data include information on race/ethnicity of patients, insurer, age,
gender, and International Classiﬁcation of Diseases – 9th revision
– Clinical Modiﬁcation (ICD-9) codes [25]. Long-term care and psy-
chiatric hospitals are excluded. These data are cleaned by HHIC and
are used as the Hawai‘i hospital data source for the major national
inpatient data-base [25].
The Queen’s Medical Center
The Queen’s Medical Center (QMC) is a 500-bed, urban,
university-aﬃliated hospital that is the largest tertiary care refer-
ral center in the Paciﬁc Basin.
Study population
We included all acute medical and surgical discharges from hos-
pitalized patients between 1/1/2007 and 12/31/2008 at QMC.
Pregnancy-related hospitalizations were excluded. We merged He-
moglobin A1c (HbA1c) and plasma glucose laboratory data fromQMC
patients with HHIC inpatient data for individuals hospitalized at QMC
during the study years. This created a sample of non-pregnancy-
related hospitalizations by any individual aged 18+ at QMC between
1/1/2007 and 12/31/2008. A total 35,321 hospitalizations were iden-
tiﬁed in this way. Hospitalizations were excluded if they did not
report race/ethnicity (n = 191) or island of residence (n = 16). This
left 35,114 hospitalizations for 24,854 unique patients. A study
sample ﬂow diagram can be seen as Fig. 1.
Methods
Diabetes diagnoses
Discharge ICD-9 codes in the HHIC data identiﬁed hospitaliza-
tions for diabetes, either uncomplicated diabetes (250.00) or diabetes
complications (250.02-–250.93).
Lab values
Labs for this study were obtained retrospectively from data col-
lected during usual care at the hospital. The HbA1c test is not part
of the routine panel. We thus have HbA1c lab values only for the
5.67% (1010/17,828) of patients who had this test ordered as part
of usual care.
Potentially undiagnosed diabetes
Potentially undiagnosed diabetes was deﬁned as HbA1c (≥6.5%)
or glucose (≥200 mg/dl). HbA1c values reﬂect mean glucose levels
over the preceding 3 months and have particular value as a diag-
nostic tool in the hospital setting as it is relatively unaffected by acute
elevations in glucose levels (stress hyperglycemia) associated with
severe illness [26,27]. However, as only a few individuals with un-
diagnosed diabetes are likely to have a HbA1c lab value taken in
the course of their hospitalization as described above, we also iden-
tiﬁed potentially undiagnosed diabetes using random plasma glucose
(RPG). Those with the ﬁrst RPG during the visit or the last RPG
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≥200 mg/dl were also considered to have potentially undiagnosed
diabetes [28].
Missing lab values
Approximately 28% of hospitalizations from individuals that did
not have diagnosed diabetes in the HHIC data were missing lab
data. As we could not estimate potentially undiagnosed diabetes
for these individuals, these cases were excluded (n = 10,124). Thus
our ﬁnal analysis sample was 24,990 hospitalizations for 17,828
patients.
Multiple hospitalizations
Among those who did not expire on index admission (n = 17,164),
we considered the total number of additional visits (beyond the
index admission) during the study period for each individual by
glucose status (i.e., diagnosed diabetes, potentially undiagnosed
diabetes, or no diabetes). Multiple visits were dichotomized into
a binary variable: yes (>1 hospitalization) vs. no (only index
hospitalization).
Race/Ethnicity
The HHIC race/ethnicity variable is created from self-reported
race/ethnicity categories available consistently across all hospitals
in Hawai‘i during the study period. Only one primary race/ethnicity
is reported. Mixed-race individuals are represented as their primary
self-reported race/ethnicity.
Other variables
For multivariable models, we considered Sex (male/female based
on administrative data), Age (categorized into 4 groups: 18–39, 40–
64, 65–84, 85+ years), Payer (Medicare, Medicaid, Private, and other)
and location of residence (lives on Oahu or on another neighbor
island in the state of Hawai‘i) as these factors are associated with
diabetes status [29]. We also compared length of stay (LOS) andmor-
tality during the hospital stay by diabetes status by race/ethnicity.
Statistical methods
Descriptive statistics were used to summarize patient charac-
teristics. Patient and hospital visit characteristics by those with
diagnosed diabetes, potentially undiagnosed diabetes, and no di-
abetes was compared using Chi-square test for categorical variables
and Kruskal–Wallis test for continuous variables. Multivariable log-
binomial models predicted diabetes (both diagnosed and potentially
undiagnosed) controlling for race/ethnicity, age, residence, gender,
and payer. Multivariable log-binomial models also predicted mul-
tiple visits during the study period (among those that did not die
on index admission). All analyses were performed in SAS 9.3 (SAS
Institute Inc.) and p < 0.05 was considered statistically signiﬁcant.
Have Lab Values  
(n=12,384 unique patients) 
Diagnosed Diabetes 
(n=5,444 unique patients) 
Multiple Visit Study Sample 
(n=17,164 unique patients) 
Prevalence Analyses Study Sample  
(n=17,828 unique patients)  
Discharge data from non-maternal, acute medical and surgical discharges 
from Queens Medical Center from 1/1/2007 to 12/31/2008 using Hawaii 
Health Information Corporation Data (n=35,321 discharges) 
Not Diagnosed Diabetes 
(n=19,410 unique patients) 
Missing Lab Values  
(n=7,026 unique patients)
Missing Race/Ethnicity 
(n=191) and Island of 
Residence (n=16)
Died in Index Stay 
(n=664 unique patients) 
35,114 hospitalizations for 24,854 unique patients
Figure 1. Study sample ﬂow chart.
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Human subjects
This study was reviewed and approved by the University of
Hawai‘i Institutional Review Board (IRB) and the Queens Medical
Center IRB.
Results
Of 24,990 hospitalizations for 17,828 patients meeting study cri-
teria, 3.4% included potentially undiagnosed diabetes and 30.5%
included diagnosed diabetes. Among those with undiagnosed di-
abetes patients (n = 603), 25.4% patients had undiagnosed diabetes
by HbA1c vs. 74.6% by RPG.
As seen in Fig. 2, the prevalence of total diabetes (diagnosed and
potentially undiagnosed) among hospitalized patients varied sig-
niﬁcantly for Native Hawaiian and Asian American subgroups
compared to Whites. (Ninety-ﬁve percent conﬁdence intervals for
prevalence estimates in Fig. 2 and for the study overall can be found
in Appendix A.) Of note, the main variation across racial/ethnic
groups was in diagnosed diabetes. While 19% of hospitalizations
amongWhites included a diabetes diagnoses, the prevalence of di-
agnosed diabetes was 32% for Chinese, 33% for Filipinos, 34% for
Japanese, and 38% for Native Hawaiians (p < 0.0001). Between 2%
and 4% of all racial/ethnic groups had potentially undiagnosed
diabetes.
Table 1 provides more demographic detail concerning those hos-
pitalized with diabetes (diagnosed and potentially undiagnosed) as
well as those with normal glucose. Variation across diabetes type
was also seen in age group (p < 0.0001), payer mix (p < 0.0001), lo-
cation of residence (p < 0.0001), but not in gender (p = 0.29). Of
interest, those hospitalized with diagnosed or potentially undiag-
nosed diabetes were, on average, 4 years older than those
hospitalized without diabetes (p < 0.0001). Also, a higher percent-
age of those with diagnosed diabetes had public payers (Medicaid
or Medicare) compared to those with potentially undiagnosed di-
abetes or no diabetes. Speciﬁcally, 69.1% (2683/5444) of those with
diagnosed diabetes had a public payer, compared to 59% (356/
603) of those with potentially undiagnosed diabetes, and 58.2% of
those with no diabetes (6855/11,781). Higher percentages of those
from Oahu were seen among those with diagnosed diabetes (87.5%;
189/5,444) compared to those with potentially undiagnosed dia-
betes (80.8%; 487/603) or no diabetes (79.6%; 9383/11,781)
(p < 0.0001). Those with potentially undiagnosed diabetes were sig-
niﬁcantly more likely to die within the index admission (9.3%; 56/
603) compared to those with diagnosed diabetes (3.5%; 189/
5444) or no diabetes (3.6%; 419/11,781) (p < 0.0001).
In multivariable models controlling for age, gender, insurance,
and place of residence (Table 2), Native Hawaiian and all Asian groups
had signiﬁcantly higher rates of diagnosed diabetes than Whites
(Native Hawaiian: RR: 1.95; 95%CI: 1.81–2.10; Chinese: RR: 1.49;
95%CI: 1.35–1.65; Filipino: RR: 1.67; 95%CI: 1.54–1.82; Japanese: RR:
1.60; 95%CI: 1.49–1.73). Those in the two middle age groups were
more likely to have diagnosed diabetes than those in the oldest age
group (85+) after adjustment, while those in the youngest age groups
were signiﬁcantly less likely. Those with public insurance, bothMed-
icaid andMedicare, were signiﬁcantly more likely to have diagnosed
diabetes compared to those with private insurance. In multivari-
able models predicting potentially undiagnosed diabetes, only older
age was a signiﬁcant predictor. No other variables were signiﬁ-
cantly associated with potentially undiagnosed diabetes in
multivariable models, including race/ethnicity.
Fig. 3 shows the impact of diabetes status on multiple hospital-
izations during the study period by individuals within race/
ethnicity for those who did not expire during the index
hospitalization. In all racial/ethnic groups, those with potentially
undiagnosed diabetes were more likely to be readmitted during the
study period than both those with diagnosed diabetes and those
without diabetes. Those with diagnosed diabetes consistently had
more hospitalizations than individuals without diabetes across racial/
ethnic groups.
Table 3 shows the adjusted models for this outcome. Potential-
ly undiagnosed diabetes was associated with signiﬁcantly more
hospitalizations during the study period than for those with no di-
abetes and those with diagnosed diabetes. Those with diagnosed
diabetes had signiﬁcantly more hospitalizations during the study
period compared to those with no diabetes. Other factors predict-
ing having more hospitalizations during the study period were older
age, living on Oahu and having public (vs. private) health insurance.
Figure 2. Total diabetes burden by race/ethnicity (n = 17,828) for individuals with diagnosed diabetes (DM), potentially undiagnosed diabetes (UnDM), and no diabetes.
Note: Among those who either had diagnosed diabetes in the administrative data or lab values.
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Table 4 shows the differences in LOS and death during hospi-
talization by diabetes type speciﬁcally for each racial/ethnic group.
In all racial/ethnic groups, those with undiagnosed diabetes had the
longest length of stay and were more likely to die during the hos-
pitalization. Within racial/ethnic groups, the differences in length
of stay and mortality, separately, by diabetes type were statistical-
ly signiﬁcant (p < 0.05) for Chinese, Filipino, Japanese, and White
patients, but not for Native Hawaiian, other Asian/Paciﬁc Islander,
or other race/ethnicity. Interestingly, within diabetes types, no sig-
niﬁcant differences were seen by race/ethnicity for LOS, though
signiﬁcant differences were seen for mortality. For all three diabe-
tes types, Chinese and Japanese were most likely to die during
hospitalization.
Discussion
In the US generally, approximately 16–25% of hospitalized pa-
tients have diagnosed diabetes [5,6]. Our study found considerably
higher rates of diabetes among hospitalized patients; 30.5% had a
known diagnosis. As hypothesized, the unadjusted diabetes prev-
alence was high for Native Hawaiians and Filipinos as well as for
other Asian subgroups. While 19% of hospitalizations amongWhites
included a diabetes diagnosis, the prevalencewas considerably higher
in all other non-White racial/ethnic groups (32% for Chinese, 33%
for Filipinos, 34% for Japanese, and 38% for Native Hawaiians).
Native Hawaiians and all Asian subgroups had similar rates of
potentially undiagnosed diabetes. In all racial/ethnic groups, between
2% and 4% had potentially undiagnosed diabetes. This is consis-
tent with the percentages of undiagnosed diabetes reported in some
other research, but lower than other reports [10–13]. For example,
a recent study that examined HbA1c levels found that 18% of hos-
pitalized patients had undiagnosed diabetes [10]. Similarly,
Umpierrez et al. examined 2030 hospitalized patients, over 50% of
whomwere Black, and found that 26% had a history of diabetes and
that 12% had hyperglycemia without a diagnosis of diabetes [14].
Measuring potentially undiagnosed diabetes is a challenge, partic-
ularly retrospectively, which likely (along with clinical and
demographic differences across studied patient populations) helps
Table 1
Description of individuals with diagnosed diabetes (DM), potentially undiagnosed diabetes (UnDM), and no diabetes among Asian American and Paciﬁc Islander subgroup
and Whites from January 2007 to December 2008a
Demographics DM UnDM No DM
Number of individuals 5444 603 11,781 17,828
N (%) N (%) N (%) P-value
Ethnicity <0.0001
Chinese 386 (7.1%) 47 (7.8%) 767 (6.5%)
Filipino 657 (12.1%) 76 (12.6%) 1230 (10.4%)
Japanese 1248 (22.9%) 119 (19.7%) 2318 (19.7%)
Other AA/PI 1017 (18.7%) 89 (14.8%) 1444 (12.3%)
Native Hawaiian 1006 (18.5%) 75 (12.4%) 1556 (13.2%)
Other race 190 (3.5%) 23 (3.8%) 709 (6.0%)
White 940 (17.3%) 174 (28.9%) 3757 (31.9%)
Gender
Female 2512 (46.1%) 272 (45.1%) 5286 (44.9%) 0.2946
Age group <0.0001
18–39 296 (5.4%) 48 (8.0%) 1886 (16.0%)
40–64 2387 (43.8%) 255 (42.3%) 4756 (40.4%)
65–84 2335 (42.9%) 225 (37.3%) 3876 (32.9%)
85+ 426 (7.8%) 75 (12.4%) 1263 (10.7%)
Payer
Medicaid/Quest 885 (16.3%) 72 (11.9%) 1732 (14.7%) <0.0001
Medicare 2873 (52.8%) 284 (47.1%) 5123 (43.5%)
Private insurance 1418 (26.0%) 187 (31.0%) 3744 (31.8%)
Other insurance 268 (4.9%) 60 (10.0%) 1182 (10.0%)
Live on Oahu
Yes 4766 (87.5%) 487 (80.8%) 9383 (79.6%) <0.0001
Expired on index admission
Yes 189 (3.5%) 56 (9.3%) 419 (3.6%) <0.0001
Mean ±SD Mean ±SD Mean ±SD
Age (years) 64.3 ± 14.7 64.0 ± 16.9 60.3 ± 19.2 <0.0001
Average hospitalizations (for those who did
not expire during index admission)
1.6 ± 1.4 2.2 ± 1.9 1.5 ± 1.2 <0.0001
a Descriptive statistics, frequency and percentage for categorical variables and means and standard deviations for continuous variable are based on individual ﬁrst visit
unless otherwise indicated.
Table 2
Predictors of diabetes (diagnosed and undiagnosed) from multivariable log-
binomial models based on patient-level data (n = 17,828)a
Diagnosed diabetes
RR [95%CI]
Undiagnosed diabetes
RR [95%CI]
Race/Ethnicity
Chinese vs. White 1.49 [1.35, 1.65] 1.07 [0.77, 1.47]
Filipino vs. White 1.67 [1.54, 1.82] 1.11 [0.85,1.44]
Hawaiian vs. White 1.95 [1.81, 2.10] 0.85 [0.65, 1.12]
Japanese vs. White 1.60 [1.49, 1.73] 0.87 [0.69, 1.10]
Other AA/PI vs. White 2.02 [1.88, 2.18] 1.07 [0.82,1.38]
Other vs. White 1.13 [0.99,1.30] 0.76 [0.50, 1.18]
Gender
Female vs. male 0.98 [0.94,1.02] 0.99 [0.85, 1.16]
Age
18–39 vs. 85+ 0.66 [0.57,0.76] 0.41 [0.27,0.63]
40–64 vs. 85+ 1.57 [1.42, 1.74] 0.69 [0.50,0.95]
65–84 vs. 85+ 1.53 [1.40, 1.67] 0.80 [0.61, 1.03]
Payer
Medicaid vs. private 1.19 [1.12, 1.28] 0.82 [0.62,1.08]
Medicare vs. private 1.28 [1.19, 1.37] 0.81 [0.63,1.04]
Other vs. Private 0.78 [0.70,0.88] 1.26 [0.94,1.68]
Island
Live in Oahu vs. not 1.02 [0.98,1.07] 1.01 [0.86, 1.18]
a Race/ethnicity, gender, age, payer, and island information was based on ﬁrst visit.
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explains the wide range of prevalence rates across previous studies.
Additionally, glucose-based measures alone, the primary measure
in our study, have been shown to underestimate undiagnosed di-
abetes prevalence [30].
Primarily due to the higher prevalence of diagnosed diabetes in
hospitalized patients, the overall burden of diabetes (both undiag-
nosed and diagnosed) is high for Native Hawaiian and Asian
subgroups. Hospitalized Native Hawaiians have a particularly high
total burden of diabetes (both diagnosed and undiagnosed) (41%)
compared to Whites (23%).
The high prevalence of diabetes among hospitalized Japanese,
Chinese, Native Hawaiians, and Filipinos compared toWhites is a new
ﬁnding and should be useful to public health care providers, health
planners, hospital administrators especially those who may be in-
terested in early detection and/or reducing health care costs. Clinically-
oriented researchers considering health disparities may also be
interested in these ﬁndings as they seek to better understand the un-
derpinnings of racial/ethnic differences in hospitalized patients.
Our results also indicate that potentially unrecognized diabe-
tes may also impact health care outcomes. The increased
rehospitalization rate for those with potentially undiagnosed dia-
betes is consistent with other studies that reported poorer clinical
outcomes, including higher mortality rates, in this group com-
pared with those with and without diagnosed diabetes [14,15]. If
this is due to unrecognized diabetes, then patients who have un-
diagnosed diabetes may appear to be healthier than they actually
are (i.e., they are not aware of a major chronic disease) and would
be unlikely to care for their chronic disease.
Health care quality reporting presents a particular incentive for
hospitals and providers, particularly those who care for large
numbers of patients with potentially undiagnosed diabetes, to iden-
tify these cases. Otherwise, patients with undiagnosed diabetes
would have none of their particular diabetes-related risk in their
charts or discharge information. Thus, this information could not
be included in risk adjustment models that might help explain poor
facility- or provider-related outcomes due to higher rates of dia-
betes in patient population. This may lead to lower scores on “report
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Figure 3. Average number of visits during study period by race/ethnicity by diabetes burden. Notes: (1) Among those who either had diagnosed diabetes in the adminis-
trative data or lab values, and also who did not expire on index admission. (2) The average number of visits by diabetes status by race/ethnicity was compared using a
non-parametric Kruskal–Wallis test. Results were as follows: diagnosed DM (p = 0.01), undiagnosed DM (p. 37), and No DM (p = 0.02). (Lack of signiﬁcance for undiagnosed
diabetes despite clear variation is likely due to low power from the small number of individuals in this comparison group.)
Table 3
Predictors of multiple visits during the study period among those who did not expire
at index admissiona
Multiple visit
RR (95%CI)
Diabetes status
Undiagnosed DM vs. no DM 1.44 [1.31, 1.60]
Diagnosed DM vs. no DM 1.09 [1.04, 1.15]
Undiagnosed DM vs. diagnosed DM 1.32 [1.19, 1.46]
Race/Ethnicity
Chinese vs. White 0.98 [0.89,1.08]
Filipino vs. White 0.85 [0.78,0.93]
Hawaiian vs. White 1.02 [0.94,1.09]
Japanese vs. White 0.94 [0.88,1.01]
Other AA/PI vs. White 1.00 [0.92,1.07]
Other vs. White 0.97 [0.87, 1.09]
Sex
Female vs. Male 0.95 [0.91, 1.01]
Age
18–39 vs. 85+ 0.81 [0.72,0.92]
40–64 vs. 85+ 0.90 [0.82,0.99]
65–84 vs. 85+ 0.85 [0.79,0.91]
Payer
Medicaid vs. private 1.26 [1.17, 1.36]
Medicare vs. private 1.27 [1.17, 1.37]
Other vs. private 0.50 [0.44,0.58]
Live in Oahu
Yes vs. no 1.98 [1.81, 2.16]
a The multivariable model for multiple visits was based on patient-level data. The
information for ethnicity, sex, age, payer and Islandwere according to ﬁrst visit. Model:
Multiple visit = diabetes status + ethnicity + sex + age group + payer +live in Oahu.
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cards” for performance than would be the case if true patient risk
was reﬂected and risk adjusted. Our ﬁnding that undiagnosed di-
abetes patients have more adverse health outcomes is strongly
supported in the literature. Providers and patients unaware of ex-
isting diabetes or early manifestation of diabetes are unlikely to treat
hyperglycemia leaving these patients more likely to experience
adverse outcomes and/or complications, especially under hospi-
talization with increased stress on glucose homeostasis [10,14,27].
Those with potentially undiagnosed diabetes in this study may
have more hospitalizations for other reasons than undiagnosed di-
abetes. They may be much sicker overall and/or they may have been
hospitalized for distinct reasons, such a trauma or chemotherapy,
for which testing for diabetes (or even coding for known diabetes)
might not be a priority. The fact that those hospitalized for poten-
tially undiagnosed diabetes in this study had higher rates of death
during the index hospitalizations supports the idea that this group
may have a high severity of illness related to conditions that were
not examined in this study. Furthermore, undiagnosed diabetes may
also be a marker of poor access to care.
Hospitalized patients present a unique opportunity for diabe-
tes screening and potential cost savings. The adverse clinical
outcomes following hospitalization suggest that more aggressive
treatment of hyperglycemia (>200 mg/dl) is warranted. Screening
with HbA1c criteria to identify those in need may be particularly
useful as glucose criteria may result in over-diagnosis. Such efforts
should be evaluated prospectively to determine if they can improve
outcomes.
Given the already high prevalence of diagnosed diabetes among
ethnic minorities in the state of Hawai‘i [2], screening of high-risk
patients in the hospital setting may reduce diabetes-related mor-
bidity as well as lower costs associated with future hospitalizations
from diabetes-related complications. However, identifying hyper-
glycemia in the hospital without a deﬁnitive diagnosis of diabetes
is also controversial, especially given the adverse affects of hypo-
glycemia thatmay result with overly aggressive glucosemanagement
[16]. Referring patients to outpatient primary care providers to as-
certain diabetes status following hospitalization may also be useful,
particularly since the diagnostic criteria for diabetes require that
patients not be under medical or physical stress.
Future work is needed to better understand the individuals iden-
tiﬁed as having potentially undiagnosed diabetes in our study. Was
their diabetes ‘missed’ completely in the hospital setting? Was a
diabetes diagnosis in the patient chart not included in the clinical
coding for some reason? Do those hospitalized with “undiag-
nosed” diabetes have distinct reasons for hospitalizations, such as
trauma? If so, howmany of those with potentially undiagnosed di-
abetes could actually beneﬁt from hospital-based screening and does
this vary by race/ethnicity?
The treatment of in-hospital hyperglycemia could potentially
reduce the high morbidity and mortality burden of this condition,
though this is understudied [14,15]. Recent trends suggest that,
indeed, practice-based factors are having an impact in reducing not
only the rates of in-hospital hyperglycemia, but also the poor out-
comes associated with this condition [16]. However, admissions that
include hypoglycemia, a potential adverse consequence of glycemic-
control treatment, are now higher than admissions including
hypoglycemia and are associated with even poorer clinical out-
comes [16]. Such issues should be considered in clinical care
management plans.
This study may have important policy implications, in large part
because of the heavy burden on the overall health care system for
hospitalized patients with diabetes. We considered payer status and
found that, even in multivariable models, those with public insur-
ance weremore likely to have diagnosed diabetes andmultiple visits.
Thus, this is an important health policy issue.
Previous studies on diabetes prevalence among hospitalized pa-
tients were not conducted in populations that included signiﬁcant
portions of Native Hawaiian, Paciﬁc Islander, or Asian American
populations. Yet this study shows stark differences by racial/
ethnic groups in terms of prevalence of diabetes in hospitalized
patients with likely consequences on both cost and outcomes. De-
creasing diabetes in these communities is a critical step for reducing
cost and improving outcomes. Our results suggest that more at-
tention to cost-effective chronic disease management generally, and
diabetes management speciﬁcally, in these high-risk racial/ethnic
groups is urgently needed [2,18,31]. These interventions should in-
tegrate “best clinical practices,” address feasibility and out-of-
pocket costs, and be culturally relevant and practical to these diverse
populations [2,18,31].
Of all ﬁve non-white populations included in this study, Native
Hawaiians showed themost extreme diabetes disparities with a total
of 41% of all Native Hawaiian admission including a diabetes diag-
nosis comparedwith national rates of only 20% of all hospitalizations
including a diabetes diagnosis designation. This suggests that the
impact of glycemic control before, during and after hospitaliza-
tion may directly impact patient outcomes and represents a
modiﬁable factor in improving health outcomes and reducing health
care costs.
This study has a number of strengths, including representation
of diverse Asian American and Paciﬁc Islander groups. Combining
Table 4
Length of stay (LOS) and mortality of individuals among Asian American and Paciﬁc Islander subgroups and Whites overall and by diagnosed diabetes (DM), potentially
undiagnosed diabetes (UnDM), and no diabetes from January 2007 to December 2008
Chinese Filipino Native Hawaiian Japanese Other AA/PI Other race White p-Value
Diagnosed DM
LOS, Mean ± SD 7.7 ± 14.1 7.8 ± 16.8 8.8 ± 17.4 7.6 ± 11.3 8.4 ± 13.7 9.9 ± 17.2 7.4 ± 11.9 0.085
Mortality (during stay), n (%) 37 (9.6%) 43 (6.5%) 53 (5.3%) 106 (8.5%) 63 (6.2%) 10 (5.3%) 49 (5.2%) 0.004
Undiagnosed DM
LOS, mean ± SD 10.6 ± 14.1 11.9 ± 18.8 8.9 ± 8.5 9.8 ± 12.9 11.5 ± 22.3 11.4 ± 17.8 13.3 ± 46.9 0.70
Mortality (during stay), n (%) 13 (27.7%) 13 (17.1%) a 32 (26.9%) a a 27 (15.5%) 0.002
No DM
LOS, mean ± SD 7.5 ± 11.7 7.4 ± 11.4 7.9 ± 16.2 7.9 ± 12.1 7.1 ± 9.7 8.7 ± 22.4 8.2 ± 17.7 0.21
Mortality (during stay), n (%) 75 (9.8%) 68 (5.5%) 73 (4.7%) 193 (8.3%) 85 (5.9%) 23 (3.2%) 202 (5.4%) <0.0001
Comparison by DM status within race/ethnicity
P-Values for LOS 0.041 <0.0001 0.095 0.0009 0.50 0.13 <0.0001
P-Values for mortality 0.0004 0.0003 0.18 <0.0001 0.49 0.20 <0.0001
a Number was analyzed, but is too small to be publically reported due to data privacy rules, which require numbers under 10 to be suppressed to protect patient
conﬁdentiality.
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these heterogeneous groups masks differences in prevalence of
disease and access to care, limiting our ability to tailor interven-
tions formaximum effectiveness to reverse these disparities [2,18,32].
Yet most population-based studies on this topic lack the sample sizes
to disaggregate these groups.
However, the study has some limitations.We did not test lab values
prospectively. Instead, we were only able to determine hospitaliza-
tions for potentially undiagnosed diabetes for individuals with lab
records. We may thus underreport undiagnosed diabetes. Compar-
ing those with and without lab data (Appendix B), those lacking lab
dataweremore likely to be female, older, live onOahu and haveMedi-
care. As advanced age is associated with diabetes generally and
potentially undiagnosed diabetes in our study, we may be underes-
timating potentially undiagnosed diabetes. On the other hand, our
glucose-based criteria for undiagnosed diabetes may be particular-
ly subject to biases in the direction of overestimating potentially
undiagnosed diabetes. High RPG can be amarker of ‘sickness” or stress,
rather than diabetes speciﬁcally, or could be due to use of steroids,
the receipt of ﬂuids containing dextrose, or many other causes [33].
In these cases, study methods may overestimate undiagnosed dia-
betes. Also, our undiagnosed diabetes guidelines are similar, though
not identical, to published guidelines indicating diabetes to be
>200mg/dl speciﬁcally with hyperglycemic symptoms or crisis [34].
These additional criteria were not included in our study. Thus, our
method of ﬁnding “potentially undiagnosed diabetes” has a low a
priori sensitivity, and we were not able to do follow-up to docu-
ment the validity of the diagnosis. Given the limitations in systematic
testing, test sensitivity, and validation in follow-up, an important area
for future research would be to determine if our prevalence numbers
are an under- or over-estimate of undiagnosed diabetes in these popu-
lations. This issue may help explain why we did not ﬁnd as many
people with undiagnosed diabetes using the currentmethods as have
been found in previous studies [10–13]. Prospective studies on this
topic that address these limitations would be useful.
We lack data regarding patients’ pathways to hospitalizations.
It is possible that some groups are disproportionately going to the
hospital when their status is more acute while others are present-
ing for more primary care. As this study also lacks lab detail for those
with diagnosed diabetes, we cannot compare the HbA1c or glucose
levels of those with diabetes by race/ethnicity to better under-
stand this acuity issue or to assess the validity of the ICD-9 based
“diabetes” determination. Thus, we cannot fully understand the dif-
ferences in the admission of patients with known diabetes who had
distinct ethnic characteristics. Interestingly, our analysis of LOS and
mortality indicate that differences are seen across several studied
racial/ethnic groups for visits within diabetes types, yet Native Ha-
waiians of all types look very similar across LOS and mortality. As
seen in other racial/ethnic minority group [35] there may be vari-
ability in HbA1c and glucose due to non-modiﬁable factors in Native
Hawaiians and other studied groups that may affect the diagnos-
tic cut off levels [36]. These may all be fruitful areas for future
research.
Other limitations have to do with the constraints of adminis-
trative data. Because ICD-9 discharge coding is for reimbursement,
it is possible these would not always include diagnosed diabetes
that appeared in the hospital chart and was used in clinical decision-
making or patient management. Patients may have a diagnosis of
diabetes, but not have this ICD-9 code on their discharge
data. However, this limitation is also a relevant research issue as
diabetes is a signiﬁcant co-morbidity that is important to capture
in discharge data for analyses purposes, including severity
adjustment.
Race/ethnicity was from hospital data and racial/ethnic identi-
ﬁcation may have varied slightly across hospitals. In 2010, the HHIC
implemented new methods to standardize race/ethnicity report-
ing across all Hawaii hospitals, and future work can consider
differences in ﬁndings using the new racial/ethnic categoriza-
tions. Also, administrative data do not contain information on many
factors that might be useful to explain or better understand dis-
parities, particularly clinical factors and social determinants [37].
These are important areas for further study. Also, our model of
multiple visits did not control for severity of illness or other
acute or chronic conditions. Finally, our ﬁndings are only from one
acute care hospital in one location. Results in other settings may
vary.
Conclusions
This study addressed a gap in our understanding of racial and
ethnic differences in diabetes in multiple, high-risk populations of
Native Hawaiian and Asian American hospitalized patients. Native
Hawaiians and all studied Asian groups had signiﬁcantly higher per-
centages of diagnosed diabetes compared to Whites, though they
did not differ signiﬁcantly in terms of prevalence of potentially un-
diagnosed diabetes. Hospitalized Native Hawaiians have a particularly
high total burden of diabetes (both diagnosed and potentially un-
diagnosed) (41%) compared to Whites (23%). Attention to cost-
effective chronic disease management generally, and diabetes
management speciﬁcally, in these high-risk racial/ethnic groups is
urgently needed.
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Appendix A
Conﬁdence interval for proportion estimates for diabetes burden by race/ethnicity estimates in Fig. 2 for individuals with diagnosed diabetes (DM), potentially undi-
agnosed diabetes (UnDM), and no diabetes (noDM)a
# of no
DM/DM/UnDM
% of
no DM
95% CI of %
for no DM2
% of
UnDM
95% CI of
% for UnDM2
% of
DM
95% CI of
% for DMb
Ethnicity
Chinese 1200 63.9% 61.2–66.7% 3.9% 2.9–5.2% 32.2% 29.4–34.7%
Filipino 1963 62.7% 60.5–64.8% 3.9% 3.1–4.9% 33.5% 31.4–35.6%
Hawaiian 2637 59.0% 57.1–60.9% 2.8% 2.2–3.5% 38.2% 36.3–40.1%
Japanese 3685 62.9% 61.3–64.5% 3.2% 2.7–3.8% 33.9% 32.4–35.5%
Other AA/PI 2550 56.6% 54.7–58.5% 3.5% 2.8–4.3% 39.9% 38.0–41.8%
Other Race 922 76.9% 74.0–79.6% 2.5% 1.6–3.7% 20.6% 18.0–23.4%
White 4871 77.1% 75.9–78.3% 3.6% 3.1–4.2% 19.3% 18.2–20.4%
Total 17,828 66.1% 65.4–66.8% 3.4% 3.1–3.7% 30.5% 29.8–31.2%
a Among those who either had diagnosed diabetes in the administrative data or lab values.
b Two-sided 95% conﬁdence interval.
Appendix B
Comparison of analysis sample and those missing lab values
Have lab values DM unknown p-value
Number of individuals 17,828 7026
Ethnicity <0.0001
Chinese 1208 (6.8%) 382 (5.4%) 0.0001
Filipino 1964 (11.0%) 637 (9.1%) <0.0001
Hawaiian 2637 (14.8%) 978 (13.9%) 0.0665
Japanese 3680 (20.7%) 1123 (16.0%) <0.0001
Other AA/PI 2539 (14.2%) 860 (12.2%) <0.0001
Other race 928 (5.2%) 545 (7.8%) <0.0001
White 4872 (27.3%) 2501 (35.6%) <0.0001
Gender <0.0001
Female 8070 (45.3%) 3478 (49.5%)
Age group <0.0001
18–39 2264 (12.7%) 2015 (28.7%) <0.0001
40–64 7419 (41.6%) 3216 (45.8%) <0.0001
65–84 6414 (36.0%) 1534 (21.8%) <0.0001
85+ 1731 (9.7%) 261 (3.7%) <0.0001
Payer <0.0001
Medicaid/Quest 2617 (14.7%) 1014 (14.4%) 0.4618
Medicare 8292 (46.5%) 1861 (26.5%) <0.0001
Private insurance 5322 (29.9%) 3218 (45.8%) <0.0001
Other 1597 (8.9%) 933 (13.3%) <0.0001
Live on Oahu 14,640 (82.1%) 5485 (78.1%) <0.0001
Expired during index hospitalization 664 (3.4%) 118 (1.7%) <0.0001
Mean ± SD Mean ± SD
Age (years) 61.5 ± 18.0 51.2 ± 18.7 <0.0001
Average # hospitalizations (for those who did
not expire on index hospitalization)
1.78 ± 1.76 1.13 ± 1.11 <0.0001
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